ARTHROPLASTY
THA: Blood loss, but not transfusion rates, lowered with combined intra- and post-op ABT
Bone Joint J. 2013 May;95-B(5):616-22. doi: 10.1302/0301-620X.95B5.30472Blood loss following total hip arthroplasty (THA) is an important procedural consideration. 204 patients who underwent primary THA were randomized to be managed by either combined intra-operative and post-operative autologous blood transfusion (ABT) or no-drainage. The purpose of the study was to determine the effect of each blood-sparing measure on blood loss, hemoglobin (Hb) level reduction, as well as the need for homologous blood transfusions. The results prior to discharge indicated that total blood loss was lower in the ABT group, and that the maximum drop in Hb level was less severe with ABT. However, mean daily post-operative Hb levels did not significantly differ, nor did the requirement for homologous blood transfusions.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
